FibroGen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. 

CEO
Thane Wettig
CEOThane Wettig
Employees
486
Employees486
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1993
Founded1993
Employees
486
Employees486

FGEN Key Statistics

Market cap
44.84M
Market cap44.84M
Price-Earnings ratio
-0.36
Price-Earnings ratio-0.36
Dividend yield
Dividend yield
Average volume
1.40M
Average volume1.40M
High today
$0.4699
High today$0.4699
Low today
$0.3813
Low today$0.3813
Open price
$0.4411
Open price$0.4411
Volume
1.56M
Volume1.56M
52 Week high
$2.80
52 Week high$2.80
52 Week low
$0.18
52 Week low$0.18

FGEN News

TipRanks 11h
FibroGen reports Q4 EPS 18c, consensus (20c)

Reports Q4 Total revenue from continuing operations for the fourth quarter of 2024 was $3.1 M, as compared to $3.6 M for the fourth quarter of 2023..Upon close...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.